1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Skin Rejuvenation Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Skin Rejuvenation Devices Market Revenue and Volume, by Product / Device Type
8.1.1. Laser & IPL Platforms
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Radiofrequency Devices
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Microneedling Devices (non-RF)
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Combination / Hybrid Platforms (Laser + RF, RF + Ultrasound, Laser + PRP integration)
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. High-Intensity Focused Ultrasound (HIFU) & Ultrasound-assisted
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. LED / Light Therapy Devices
8.1.6.1. Market Revenue and Volume Forecast
8.1.7. Cryotherapy / CoolSculpting-adjunct & Other Modalities
8.1.7.1. Market Revenue and Volume Forecast
9.1. Skin Rejuvenation Devices Market Revenue and Volume, by Technology
9.1.1. Ablative fractional
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Picosecond & Q-switched (Fastest Growing for pigmentation & tattoo retreatment).
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Microneedle RF
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. IPL broad-band
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. LED photobiomodulation
9.1.5.1. Market Revenue and Volume Forecast
10.1. Skin Rejuvenation Devices Market Revenue and Volume, by Indication / Clinical Use
10.1.1. Wrinkle Reduction & Skin Tightening
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Pigmentation & Melasma Management
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Scar & Acne-scar Remodeling
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Texture / Pore Reduction & Skin Quality
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Vascular Lesions & Rosacea
10.1.5.1. Market Revenue and Volume Forecast
10.1.6. Overall Rejuvenation & Combination Protocols
10.1.6.1. Market Revenue and Volume Forecast
11.1. Skin Rejuvenation Devices Market Revenue and Volume, by End User / Channel
11.1.1. Dermatology & Plastic Surgery Clinics (Dominant)
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Medspas & Cosmetic Chains
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Hospitals & Ambulatory Surgery Centers
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. At-home / Consumer FDA-cleared devices
11.1.4.1. Market Revenue and Volume Forecast
12.1. Skin Rejuvenation Devices Market Revenue and Volume, by Revenue Model / Component
12.1.1. Capital equipment sales
12.1.1.1. Market Revenue and Volume Forecast
12.1.2. Consumables, tips & disposable cartridges
12.1.2.1. Market Revenue and Volume Forecast
12.1.3. Service, training & software (SaaS, AI diagnostics, imaging add-ons)
12.1.3.1. Market Revenue and Volume Forecast
14.1. North America
14.1.1. Market Revenue and Volume Forecast, by Product / Device Type
14.1.2. Market Revenue and Volume Forecast, by Technology
14.1.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.1.4. Market Revenue and Volume Forecast, by End User / Channel
14.1.5. Market Revenue and Volume Forecast, by Revenue Model / Component
14.1.6. Market Revenue and Volume Forecast, by June
14.1.7. U.S.
14.1.7.1. Market Revenue and Volume Forecast, by Product / Device Type
14.1.7.2. Market Revenue and Volume Forecast, by Technology
14.1.7.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.1.7.4. Market Revenue and Volume Forecast, by End User / Channel
14.1.8. Market Revenue and Volume Forecast, by Revenue Model / Component
14.1.8.1. Market Revenue and Volume Forecast, by June
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Volume Forecast, by Product / Device Type
14.1.9.2. Market Revenue and Volume Forecast, by Technology
14.1.9.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.1.9.4. Market Revenue and Volume Forecast, by End User / Channel
14.1.10. Market Revenue and Volume Forecast, by Revenue Model / Component
14.1.11. Market Revenue and Volume Forecast, by June
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Volume Forecast, by Product / Device Type
14.2.2. Market Revenue and Volume Forecast, by Technology
14.2.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.2.4. Market Revenue and Volume Forecast, by End User / Channel
14.2.5. Market Revenue and Volume Forecast, by Revenue Model / Component
14.2.6. Market Revenue and Volume Forecast, by June
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Volume Forecast, by Product / Device Type
14.2.8.2. Market Revenue and Volume Forecast, by Technology
14.2.8.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.2.9. Market Revenue and Volume Forecast, by End User / Channel
14.2.10. Market Revenue and Volume Forecast, by Revenue Model / Component
14.2.10.1. Market Revenue and Volume Forecast, by June
14.2.11. Germany
14.2.11.1. Market Revenue and Volume Forecast, by Product / Device Type
14.2.11.2. Market Revenue and Volume Forecast, by Technology
14.2.11.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.2.12. Market Revenue and Volume Forecast, by End User / Channel
14.2.13. Market Revenue and Volume Forecast, by Revenue Model / Component
14.2.14. Market Revenue and Volume Forecast, by June
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Volume Forecast, by Product / Device Type
14.2.15.2. Market Revenue and Volume Forecast, by Technology
14.2.15.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.2.15.4. Market Revenue and Volume Forecast, by End User / Channel
14.2.16. Market Revenue and Volume Forecast, by Revenue Model / Component
14.2.16.1. Market Revenue and Volume Forecast, by June
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Volume Forecast, by Product / Device Type
14.2.17.2. Market Revenue and Volume Forecast, by Technology
14.2.17.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.2.17.4. Market Revenue and Volume Forecast, by End User / Channel
14.2.18. Market Revenue and Volume Forecast, by Revenue Model / Component
14.2.18.1. Market Revenue and Volume Forecast, by June
14.3. APAC
14.3.1. Market Revenue and Volume Forecast, by Product / Device Type
14.3.2. Market Revenue and Volume Forecast, by Technology
14.3.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.3.4. Market Revenue and Volume Forecast, by End User / Channel
14.3.5. Market Revenue and Volume Forecast, by Revenue Model / Component
14.3.6. Market Revenue and Volume Forecast, by June
14.3.7. India
14.3.7.1. Market Revenue and Volume Forecast, by Product / Device Type
14.3.7.2. Market Revenue and Volume Forecast, by Technology
14.3.7.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.3.7.4. Market Revenue and Volume Forecast, by End User / Channel
14.3.8. Market Revenue and Volume Forecast, by Revenue Model / Component
14.3.9. Market Revenue and Volume Forecast, by June
14.3.10. China
14.3.10.1. Market Revenue and Volume Forecast, by Product / Device Type
14.3.10.2. Market Revenue and Volume Forecast, by Technology
14.3.10.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.3.10.4. Market Revenue and Volume Forecast, by End User / Channel
14.3.11. Market Revenue and Volume Forecast, by Revenue Model / Component
14.3.11.1. Market Revenue and Volume Forecast, by June
14.3.12. Japan
14.3.12.1. Market Revenue and Volume Forecast, by Product / Device Type
14.3.12.2. Market Revenue and Volume Forecast, by Technology
14.3.12.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.3.12.4. Market Revenue and Volume Forecast, by End User / Channel
14.3.12.5. Market Revenue and Volume Forecast, by Revenue Model / Component
14.3.12.6. Market Revenue and Volume Forecast, by June
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Volume Forecast, by Product / Device Type
14.3.13.2. Market Revenue and Volume Forecast, by Technology
14.3.13.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.3.13.4. Market Revenue and Volume Forecast, by End User / Channel
14.3.13.5. Market Revenue and Volume Forecast, by Revenue Model / Component
14.3.13.6. Market Revenue and Volume Forecast, by June
14.4. MEA
14.4.1. Market Revenue and Volume Forecast, by Product / Device Type
14.4.2. Market Revenue and Volume Forecast, by Technology
14.4.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.4.4. Market Revenue and Volume Forecast, by End User / Channel
14.4.5. Market Revenue and Volume Forecast, by Revenue Model / Component
14.4.6. Market Revenue and Volume Forecast, by June
14.4.7. GCC
14.4.7.1. Market Revenue and Volume Forecast, by Product / Device Type
14.4.7.2. Market Revenue and Volume Forecast, by Technology
14.4.7.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.4.7.4. Market Revenue and Volume Forecast, by End User / Channel
14.4.8. Market Revenue and Volume Forecast, by Revenue Model / Component
14.4.9. Market Revenue and Volume Forecast, by June
14.4.10. North Africa
14.4.10.1. Market Revenue and Volume Forecast, by Product / Device Type
14.4.10.2. Market Revenue and Volume Forecast, by Technology
14.4.10.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.4.10.4. Market Revenue and Volume Forecast, by End User / Channel
14.4.11. Market Revenue and Volume Forecast, by Revenue Model / Component
14.4.12. Market Revenue and Volume Forecast, by June
14.4.13. South Africa
14.4.13.1. Market Revenue and Volume Forecast, by Product / Device Type
14.4.13.2. Market Revenue and Volume Forecast, by Technology
14.4.13.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.4.13.4. Market Revenue and Volume Forecast, by End User / Channel
14.4.13.5. Market Revenue and Volume Forecast, by Revenue Model / Component
14.4.13.6. Market Revenue and Volume Forecast, by June
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Volume Forecast, by Product / Device Type
14.4.14.2. Market Revenue and Volume Forecast, by Technology
14.4.14.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.4.14.4. Market Revenue and Volume Forecast, by End User / Channel
14.4.14.5. Market Revenue and Volume Forecast, by Revenue Model / Component
14.4.14.6. Market Revenue and Volume Forecast, by June
14.5. Latin America
14.5.1. Market Revenue and Volume Forecast, by Product / Device Type
14.5.2. Market Revenue and Volume Forecast, by Technology
14.5.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.5.4. Market Revenue and Volume Forecast, by End User / Channel
14.5.5. Market Revenue and Volume Forecast, by Revenue Model / Component
14.5.6. Market Revenue and Volume Forecast, by June
14.5.7. Brazil
14.5.7.1. Market Revenue and Volume Forecast, by Product / Device Type
14.5.7.2. Market Revenue and Volume Forecast, by Technology
14.5.7.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.5.7.4. Market Revenue and Volume Forecast, by End User / Channel
14.5.8. Market Revenue and Volume Forecast, by Revenue Model / Component
14.5.8.1. Market Revenue and Volume Forecast, by June
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Volume Forecast, by Product / Device Type
14.5.9.2. Market Revenue and Volume Forecast, by Technology
14.5.9.3. Market Revenue and Volume Forecast, by Indication / Clinical Use
14.5.9.4. Market Revenue and Volume Forecast, by End User / Channel
14.5.9.5. Market Revenue and Volume Forecast, by Revenue Model / Component
14.5.9.6. Market Revenue and Volume Forecast, by June
15.1. Lumenis
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Candela / Syneron Candela
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Cutera
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Alma Lasers
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Cynosure (Hologic)
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Sciton
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Fotona
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Lutronic
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. InMode
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. BTL Aesthetics
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client